Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2026-03-27 @ 6:52 PM
Study NCT ID:
NCT06672068
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-12-30
First Post:
2024-11-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC
Sponsor:
TYK Medicines, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TYKM1601203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None